Equities

Elan Corp

Elan Corp

Actions
Health CareHealth Care Providers
  • Price (JPY)699.00
  • Today's Change-11.00 / -1.55%
  • Shares traded131.60k
  • 1 Year change-28.89%
  • Beta1.4316
Data delayed at least 20 minutes, as of Nov 22 2024 03:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5,4896,0365,632
Total Receivables, Net8,0286,6265,362
Total Inventory1,8991,3321,080
Prepaid expenses------
Other current assets, total918256
Total current assets15,50714,07612,130
Property, plant & equipment, net540561341
Goodwill, net----9.77
Intangibles, net1099296
Long term investments2,171737942
Note receivable - long term------
Other long term assets14614279
Total assets18,99316,07213,948
LIABILITIES
Accounts payable6,4275,5684,868
Accrued expenses205198306
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1,4561,2461,242
Total current liabilities8,0897,0126,417
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total907147
Total liabilities8,1797,0826,464
SHAREHOLDERS EQUITY
Common stock573573573
Additional paid-in capital543543543
Retained earnings (accumulated deficit)9,9648,1126,575
Treasury stock - common(194)(194)(197)
Unrealized gain (loss)(73)(45)(11)
Other equity, total0.000.000.00
Total equity10,8148,9907,484
Total liabilities & shareholders' equity18,99316,07213,948
Total common shares outstanding606060
Treasury shares - common primary issue0.140.140.14
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.